About
Translumina Therapeutics is a leading company in interventional cardiovascular devices, established in 2000 in Germany. The company specializes in manufacturing advanced coronary intervention products, particularly drug-eluting stents known for their quality and clinical performance. With three state-of-the-art manufacturing facilities in Germany, the Netherlands, and India, Translumina adheres to international quality standards, ensuring safety and reliability in its offerings. The company is committed to innovation and improving patient outcomes in coronary care, operating in over 60 countries. Its product range includes drug-eluting stents, drug-eluting balloons, and precision vascular accessories, all designed to enhance safety and efficacy in cardiovascular interventions. Translumina also invests significantly in research and development to advance medical science in this field. Collaborating with hospitals, cardiologists, and technology companies, Translumina focuses on delivering life-saving cardiovascular technologies globally.
Technologies
Keywords
Company Information
-
Employees 380
-
Founded 2010
-
Annual Revenue $24501000
-
Total Funding $69700000
Location
New Delhi, Delhi, India
